Literature DB >> 8513036

Altered platelet protein kinase C activity in bipolar affective disorder, manic episode.

E Friedman1, D Levinson, T A Connell, H Singh.   

Abstract

Protein kinase C (PKC) activity and PKC translocation in response to serotonin were investigated in platelets obtained from bipolar affective disorder subjects before and during lithium treatment. Ratios of platelet membrane-bound to cytosolic PKC activities were elevated in the manic subjects. In addition, serotonin-elicited platelet PKC translocation was found to be enhanced in those subjects. Lithium treatment for up to 2 weeks resulted in a reduction in cytosolic and membrane-associated PKC activities and in an attenuated PKC translocation in response to serotonin. These preliminary results suggest that alteration in platelet PKC is associated with the manic phase of bipolar illness. The results also suggest that lithium treatment reduces the sensitivity of platelets to PKC translocation induced by activation of serotonin-2 receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513036     DOI: 10.1016/0006-3223(93)90006-y

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  45 in total

Review 1.  New therapeutic targets for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Nancy DiazGranados; Lobna Ibrahim; David Latov; Cristina Wheeler-Castillo; Jacqueline Baumann; Ioline D Henter; Carlos A Zarate
Journal:  ScientificWorldJournal       Date:  2010-04-13

2.  Dopamine D(3) receptors are down-regulated following heterologous endocytosis by a specific interaction with G protein-coupled receptor-associated sorting protein-1.

Authors:  Dawn Thompson; Jennifer L Whistler
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

3.  The underlying neurobiology of bipolar disorder.

Authors:  Husseini K Manji; Jorge A Quiroz; Jennifer L Payne; Jaskaran Singh; Barbara P Lopes; Jenilee S Viegas; Carlos A Zarate
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

4.  Decreased protein kinase C (PKC) in platelets of pediatric bipolar patients: effect of treatment with mood stabilizing drugs.

Authors:  Ghanshyam N Pandey; Xinguo Ren; Yogesh Dwivedi; Mani N Pavuluri
Journal:  J Psychiatr Res       Date:  2007-01-08       Impact factor: 4.791

Review 5.  A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?

Authors:  Erika Abrial; Guillaume Lucas; Hélène Scarna; Nasser Haddjeri; Laura Lambás-Señas
Journal:  Mol Neurobiol       Date:  2011-10-05       Impact factor: 5.590

Review 6.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

Review 7.  A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.

Authors:  Nancy DiazGranados; Carlos A Zarate
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

Review 8.  Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder.

Authors:  Mark J Niciu; Dawn F Ionescu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  CNS Spectr       Date:  2013-03-11       Impact factor: 3.790

Review 9.  Potential mechanisms of action of lithium in bipolar disorder. Current understanding.

Authors:  Gin S Malhi; Michelle Tanious; Pritha Das; Carissa M Coulston; Michael Berk
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

10.  Human disease-drug network based on genomic expression profiles.

Authors:  Guanghui Hu; Pankaj Agarwal
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.